Lynn A. Tetrault's Net Worth

$1.74 Million

Estimate Recalculated Jun 3, 2025 10:21PM EST

Who is Lynn A. Tetrault

Lynn A. Tetrault has an estimated net worth of $1.74 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., NEOGENOMICS INC, and ACELYRIN, Inc..

SEC CIK

Lynn A. Tetrault's CIK is 0001645512

Past Insider Trading and Trends

2024 was Lynn A. Tetrault's most active year for acquiring shares with 9 total transactions. Lynn A. Tetrault's most active month to acquire stocks was the month of May. 2024 was Lynn A. Tetrault's most active year for disposing of shares, totalling 8 transactions. Lynn A. Tetrault's most active month to dispose stocks was the month of July. 2024 saw Lynn A. Tetrault paying a total of $123,157.00 for 111,242 shares, this is the most they've acquired in one year. In 2024 Lynn A. Tetrault cashed out on 49,048 shares for a total of $759,069.31, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC.

Investor
Updated Sep 11, 2024
Form 4
-87.34%
-20.70K
$30.77
-$784.30K
Sep 11, 2024
3.00K
Sale
ScheduledSep 09 - Sep 10
Form 4
-23.89%
-4.30K
$34.50
-$133.37K
Aug 28, 2024
13.70K
Sale
ScheduledAug 26
Form 4
-43.48%
-10.00K
$24.40
-$404.96K
Aug 14, 2024
13.00K
Sale
ScheduledAug 12
Form 4
Jun 25, 2024
3.00K
Options
Jun 21
Form 4
18.00K
Jun 20, 2024
18.00K
Grant
Jun 18
Form 4
17.00K
Jun 23, 2023
17.00K
Grant
Jun 21
Form 4
20.00K
Jun 10, 2022
20.00K
Grant
Jun 08
Form 4
15.00K
Jun 11, 2021
15.00K
Grant
Jun 09
Form 4
37.00K
Dec 11, 2020
37.00K
Grant
Dec 09
Form 3
Dec 11, 2020
Showing 10 results

NEOGENOMICS INC

Investor
Updated Aug 13, 2024
Form 4
Aug 13, 2024
114.83K
Options
Aug 10
Form 4
20.93K
Jun 04, 2024
114.83K
Grant
Jun 01
Form 4
-10.88%
-6.11K
$15.97
-$97.58K
Mar 06, 2024
93.90K
Sale
ScheduledMar 04
Form 4
19.69K
Aug 14, 2023
100.02K
Grant
Aug 10
Form 4
$11.60
$17.48K
May 24, 2023
80.33K
Options
May 22
Form 4
75.27%
29.44K
Jun 14, 2022
80.33K
Grant
Jun 10
Form 4
$7.27
$24.24K
May 20, 2022
50.89K
Options
May 18
Form 4
5.18%
1.81K
Oct 13, 2021
50.89K
Grant
Oct 11
Form 4
$9.11
$12.65K
Jun 14, 2021
49.08K
Options
Jun 11
Form 4
22.30%
6.79K
Jun 04, 2021
49.08K
Grant
Jun 02
Form 4
14.76%
6.15K
Jun 01, 2020
64.53K
Grant
May 28
Form 4
20.11%
7.69K
Jun 10, 2019
58.38K
Grant
Jun 06
Form 4
-25.37%
-13.00K
$16.00
-$207.94K
Nov 21, 2018
50.70K
Sale
Nov 19
Form 4
-7.61%
-5.00K
$11.83
$60.64K
Nov 16, 2018
63.70K
Sale
Nov 14 - Nov 15
Form 4
85.30%
18.58K
Jun 05, 2018
68.70K
Grant
Jun 01
Form 4
85.70%
18.67K
$7.27
$72.70K
May 30, 2017
73.34K
Options
May 25 - May 30
Form 4
69.20%
13.40K
$9.11
$75.91K
Jul 29, 2016
66.71K
Grant
Jul 28
Form 4
14.77%
2.15K
$7.15
$15.37K
May 03, 2016
41.27K
Grant
Apr 20
Form 4
187.75%
9.50K
$8.21
$78.00K
Dec 23, 2015
24.56K
Purchase
Dec 21
Form 4
224.36%
3.50K
$7.72
$27.02K
Dec 09, 2015
15.06K
Purchase
Dec 07
Form 4
10.00K
$6.66
$66.60K
Jul 15, 2015
11.56K
Grant
Jul 15
Form 3
Jun 23, 2015
1.56K
Showing 22 results

ACELYRIN, Inc.

Investor
Updated Jun 11, 2024
Form 4
43.68K
Jun 11, 2024
43.68K
Grant
Jun 07
Form 4
89.95K
Dec 20, 2023
89.96K
Grant
Dec 18
Form 3
Dec 20, 2023
Showing 3 results